{"id": "1216699107164786688", "created_at": "2020-01-13T12:30:46.000Z", "text": "$BIIB $PFE Biogen to Acquire Novel Clinical Stage Asset with Application in #Alzheimer's Disease and #Parkinson's Disease from Pfizer Inc.", "author_id": "4859660471"}
{"id": "1216765295634894849", "author_id": "90846058", "text": "$ACST $AMRN Lots of eyes on it now!! $AMRX JNJ $ROG $PFE $NVS $BAYN $GSK $MRK $SNY $ABBV $ABT $LLY $AMGN $BMY $GILD $AZN $TEVA $TYO $NVO $AGN $DHR $CELG $BIIB $LH $BAX $MYL $RHBBY", "created_at": "2020-01-13T16:53:47.000Z"}
{"id": "1216715905004163074", "created_at": "2020-01-13T13:37:31.000Z", "text": "$PFE looking for a run at open out of this bull flag from end of Friday. JPM healthcare conference is this week and PFE is presenting tomorrow. Could see some potential big news or deals etc. ER is also end of the month on 1/28 4 hr chart is a beauty https://t.co/8XoKBQQEWS", "author_id": "979704805051588608"}
{"id": "1216784223299940352", "author_id": "1136370591517290496", "text": "RT @BioStocks: $AXSM &amp; $PFE Exclusive License Agreement For Reboxetine Clinical and Nonclinical Data and for New Phase 3 Esreboxetine Produ\u2026", "created_at": "2020-01-13T18:09:00.000Z"}
{"id": "1216736580712398851", "author_id": "1136370591517290496", "text": "RT @InsiderBiotech: $AXSM $PFE license agreement for AXS-12 and AXS-14  Pfizer to receive $11 million in Axsome stock and upfront cash, and\u2026", "created_at": "2020-01-13T14:59:41.000Z"}
{"id": "1216739753602752514", "author_id": "1136370591517290496", "text": "RT @jodigralnick: #JPM20 starts tomorrow! Join @megtirrell and @jimcramer all day Monday &amp; Tuesday, for \na stellar lineup of interviews you\u2026", "created_at": "2020-01-13T15:12:17.000Z"}
{"id": "1216679914574958592", "created_at": "2020-01-13T11:14:31.000Z", "text": "$ZYME $PFE $AZN - Zymeworks teams up with Pfizer in breast cancer study https://t.co/DkVx0LDB2f", "author_id": "822647284299157504"}
{"id": "1216824788234031106", "author_id": "733717446", "text": "RT @syinvesting: $AXSM / $PFE Agreement:\n\n- U.S. license to reboxetine (API in AXS-12 in narcolepsy)\n- Exclusive rights to esreboxetine (no\u2026", "created_at": "2020-01-13T20:50:11.000Z"}
